首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到19条相似文献,搜索用时 203 毫秒
1.
目的:通过对长沙汉族人群TGFB1的多态分布规律的研究,从遗传流行病学的角度探讨TGFB1 SNPs(单核甘酸多态性)与长沙汉族人群脑卒中的关系。方法:应用PCR、RFLP及DNA直接测序等方法对研究人群进行-509C>T及+869T>C基因分型。研究对象包括:脑梗死(CI)患者186例,脑出血(CH)患者202例,正常对照人群160例。结果:脑梗死组(CI)和脑出血组(CH)分别与对照组比较,-509C>T和+869T>C基因型及等位基因频率分布无统计学差异(P>0.05),有脑梗死家族史的患者(FCI组)与对照组比较,-509 T等位基因携带者及+869C等位基因携带者频率较高(P<0.05),其中-509 T携带者脑梗死的患病风险为对照组的1.557倍,+869C携带者脑梗死的患病风险为对照组的1.45倍。结论:TGFB1-509C>T及+869T>C与有脑梗死家族史的长沙汉族人群脑梗死发病可能相关,但与有脑出血家族史的长沙汉族人群脑出血发病无关,-509T和+869C等位基因可能是有脑梗死家族史的长沙汉族人群脑梗死发病的危险因子。  相似文献   

2.
MTHFR基因C677T多态性与内蒙古汉族人群中冠心病的关系   总被引:1,自引:0,他引:1  
目的:检测中国内蒙古汉族人群中MTHFR基因多态性与冠心病的关系.方法:研究组包括62例冠心病(coronary heartdisease,CHD)患者和120例正常对照人群,用聚合酶链反应-限制性片段长度多态性技术(PCR-RFLP)分析C677T型突变.结果:677T/T基因型在冠心病人群中更普遍,是正常人群的3.4倍.结论:在内蒙古汉族人群中,677T/T基因型增加了个体患冠心痛的风险性.  相似文献   

3.
目的:探讨中国粤西地区汉族人群ABCB1基因C3435T (rs1045642)的单核苷酸多态性与耐药性癫痫的关系.方法:研究对象128例,包括正常对照组60例和癫痫组68例.根据患者对抗癫痫药物的反应性将癫痫组分为耐药组(30例)和药物敏感组(38例).提取所有研究对象外周血基因组DNA,采用PCR扩增后基因测序鉴定ABCB1基因C3435T多态性.测定该位点基因型频率和等位基因频率,并进行统计学分析.结果:各组ABCB1基因C3435T基因型频率的分布符合Hardy-Weinburg平衡,提示其来自同一孟德尔群体.正常对照组与药物敏感组及耐药组,药物敏感组与耐药组间基因型频率比较,差异均无统计学意义(P>0.05).正常对照组与药物敏感组及耐药组,药物敏感组与耐药组间等位基因型频率比较,差异亦无统计学意义(P>0.05).结论:本研究结果初步证实ABCB1基因C3435T位点多态性分布与耐药性癫痫之间无相关性.  相似文献   

4.
DNMT1(DNA(cytosine-5)-methyltransferase 1)在神经管的闭合过程中发挥重要作用,已有研究表明,DNMT1敲除的小鼠会出现神经管畸形(neural tube defects,NTDs)的表型.为了进一步探索DNMT1基因错义突变与神经管畸形发生的相关性,本研究对来自中国汉族人群的101例神经管畸形患者血液样本和171例正常对照血液样本中提取的基因组DNA进行了全基因组测序.在这些病例的DNM T1基因上一共检测到了5个病例特有的错义突变,其中c.2626G>A和c.4381C>T突变在不同物种间高度保守,并且c.4381C>T突变在公共数据库中没有记录.蛋白免疫印迹实验显示c.290A>G,c.358G>C,c.410C>G,c.2626G>A和c.4381C>T这5个突变都使DNMT1蛋白表达量下调.免疫荧光实验显示这5个突变不影响DNMT1蛋白的核定位.我们的研究表明病例样本中DNMT1上鉴定到的5个病例特有的错义突变可能通过下调DNMT1的蛋白表达量而导致神经管畸形的发生.  相似文献   

5.
目的:研究促红细胞生成素(EPO)基因T3541G单核苷酸多态性(SNP/C1772T)在中国北方汉族人群中的分布特征.方法:通过PCR-RFLP实验方法,解析206名中国北方汉族人群EPO基因SNP/T3541G.结果:中国北方汉族人辟EPO基因SNP/T3541G多态位点的基因型符合Hardy-Weinberg遗传...  相似文献   

6.
目的:探讨醛糖还原酶(AR)基因启动区C(-106)T多态性与糖尿病视网膜病变(DR)的关系.方法:235例江苏汉族人群.其中2型糖尿病无视网膜病变组(NDR)63例,2型糖尿病伴视网膜病变组(DR)82例.正常对照组(NC)90例,用PCR-RFLP方法检测AR基因C(-106)T基因型.比较各组等位基因及基因型分布频率.结果:未发现NDR组和NC组之间AR基因C(-106)T各等位基因及基因型频率有显著差异(P分别为0.4505,0.7279);DR组中CT及TT基因型频率均高于NC组,CC基因型频率低于NC组(P=0.0239),DR组T等位基因频率显著高于NC组.C等位基因频率显著低于NC组(P=0.0038).结论:AR基因启动区C(-106)T多态性与江苏汉族人群DR相关,T等位基因可能是DR的遗传危险因子.  相似文献   

7.
为研究汉族人白细胞介素-1β(IL-1β)基因-511T>C和 3954C>T位点单核苷酸多态性与腰椎间盘疾病的关系,采用聚合酶链反应技术,扩增81例腰椎间盘疾病患者和101例正常对照者中分别包含IL-1β基因-511T>C和 3954C>T位点的片段,酶切法鉴定IL-1β基因-51iT>C和 3954C>T位点单核苷酸多态性情况,比较两组中基因多态性与腰椎间盘疾病的关系.同时,利用MRI检测两组腰椎间盘退变的情况,并分析其中小于45岁者IL-1β基因多态性与腰椎间盘退变严重程度的关系.结果显示,腰椎间盘疾病病例组及对照组中均存在IL-1β基因-511T>C和 3954C>T位点单核苷酸多态性.IL-1β基因-511T>C位点TT、TC和CC基因型,T,C基因型差别与腰椎间盘疾病有关(P<0.01),与腰椎间盘退变严重程度无关(P>0.05),但IL-1β基因 3954C>T位点单核苷酸多态性与腰椎间盘退变严重程度及腰椎间盘疾病均无关(P>0.05).表明在汉族人中,存在IL-1β基因-511T>C和 3954C>T位点单核苷酸多态性,但仅-511T>C位点单核苷酸多态性与腰椎间盘疾病有关.  相似文献   

8.
目的:探讨青岛地区汉族人群阿司匹林抵抗与血小板膜糖蛋白GPⅢaPLA、Ⅰ a807C/T基因多态性之间的关系.方法:筛选150例动脉粥样硬化患者服用阿司匹林(100mg/d)至少14d以上,根据血小板聚集功能测定将其分为阿司匹林抵抗(AR)组、阿司匹林半抵抗(ASR)组,阿司匹林敏感(AS)组.用PCR-RFLP法确定各组GPⅢaPLA、GP Ⅰa 807C/T基因型.结果:仅于ASR组检出1例PLA1/A2基因型,其余均为PLA1/A1基因型,未发现PLA2/A2基因型,差异无统计学意义(P>0.005);GP Ⅰ a807C/T基因位点AR组、ASR组的T等位基因频率均显著高于AS组,有统计学意义(P<0.005).结论:GPⅢaPLA2基因可能不是阿司匹林抵抗的遗传危险因素.而GP Ⅰ a 807C/T基因位点的T等位基因与阿司匹林抵抗的发生相关联,可能是阿司匹林抵抗遗传易感因素.  相似文献   

9.
为了分析汉族人群一氧化氮合酶基因NOS3 A-922G、NOS3 T-786C与NOS3 G894T单核苷酸多态性(sin-gle nucleotide polymorphism,SNP)的等位基因及其组合分布与高血压病的相关性,选取无亲缘关系的高血压病人192例(男97例,女95例)以及无亲缘关系的健康个体122例(男76例,女46例)为对照组,提取静脉血白细胞基因组DNA,采用等位基因特异性引物PCR技术检测NOS3 A-922G、NOS3 T-786C与NOS3 G894T 3个位点的基因型.其结果显示:高血压病组与对照组NOS3 G894T、NOS3A-922G及NOS3 T-786C各等位基因型及其基因单倍型频率比较无显著性差异(P>0.05).男、女性别分层研究:无论男亚组还是女亚组均未发现NOS3 A-922G、NOS3T-786C与NOS3 G894T各个位点SNP与高血压病有相关性.等位基因组合分布研究发现NOS3 G894G A-922G T-786T组合基因型总体频率分布在高血压病组与正常对照组之间有显著性差异(P<0.05,x2=4.5944).男、女性别分层研究:男亚组上述3个位点SNP的各个组合基因型分布频率在高血压病组与正常对照组之间无显著性差异(P>0.05);女亚组中携带NOS3 G894G A-922G T-786C的组合基因型分布频率在高血压病组与正常对照组之间有显著性差异(P<0.01,x2=8.502).研究发现,在中国汉族人群中NOS3A-922 G、NOS3 T-786C与NOS3G894T SNP与高血压病无明确的相关性,且无性别差异.组合分布研究发现,NOS3 G894G A-922G T-786C的组合基因型分布频率在高血压病女性亚组较健康女性亚组明显减低,提示携带该组合基因型女性人群可能不易患高血压病.  相似文献   

10.
目的:探讨湖北汉族人群中白细胞介素6受体基因(interleukin 6 receptorgene,IL6R)g 9外显子D358A多态与2型糖尿病(type 2 diabetes mellitus,T2DM)的关联.方法:采取病例-同胞对照和随机病例一对照两种实验设计,应用聚合~t-tt反应一限制性酶切片段长度多态性(PCR-RFLP)方法,对571例样本IL6R基因第9外显子D358A多态进行分析.结果:在所有样本及两种实验设计中,病例组与对照组基因型频率存在显著差异(P<0.05),所有样本和随机样本设计中,T2DM组C等位基因频率显著低于对照组(P<0.05),病例.同胞对样本设计中未发现显著差异(P>0.05).单因素Logistic回归分析发现,CC基因型与T2DM显著相关(P<0.05).结论:在中国湖北汉族人群中,IL6R基因第9外显子D358A多态性与2型糖尿病相关联,CC基因型是T2DM的保护因子.  相似文献   

11.
Transforming growth factor-β1 (TGF-β1) is a ubiquitous and essential cytokine that plays a dual role in the development of cancer: tumor suppressor in the early stage of carcinogenesis and tumor promoter in the later stage of carcinogenesis. To date, several studies have focused on the association between the TGFB1 polymorphisms and risk of gastric cancer. Conflicting results, however, have been reported. We conducted a meta-analysis to analyze more precisely the effects of the TGFB1 C-509T, T869C, and G915C polymorphisms on the risk of gastric cancer. No significant association between the TGFB1 C-509T, T869C, and G915C polymorphisms and risk of gastric cancer was observed in overall analyses and subgroup analyses according to ethnicity.  相似文献   

12.
13.
李洁  许宏伟 《激光生物学报》2010,19(4):446-448,438
目的:研究载脂蛋白A5基因编码区56C〉G这一多态性位点与动脉粥样硬化性脑梗死(atherosclerotic cerebral infarction, ACI )及与血脂的关系。方法:选择170例ACI患者和171例健康人,应用聚合酶链反应一限制片长多态性的原理,逐个鉴定每个个体的基因型。结果:56C〉G这一位点多态性在研究人群未被发现。结论:56C〉G位点在研究人群中可能不是一个多态性位点,可能与ACI及血脂无关联。  相似文献   

14.
目的:探讨中国汉族人群中miR-146aC〉G,miR-149T〉C基因多态性与缺血性脑卒中易感性的关系。方法:利用聚合酶链式反应-限制性片段长度多态性(PCR-RFLP)的方法检测196例缺血性脑卒中患者和205例健康对照中miR-146aC〉G,miR-149T〉C的基因型,统计学方法比较两组间基因型及等位基因分布差异。结果:miR-146aC〉G位点各基因型在病例组和对照组分布无明显差异,但等位基因G会增加缺血性脑卒中的患病风险;miR-149T〉C位点各基因型在病例组和对照组分布无明显差异。在分层分析中,miR-146aC〉G会增加女性和非高血压患者缺血性脑卒中的患病风险,miR-149T〉C会增加非高血压患者缺血性脑卒中的患病风险。结论:miR-146aG等位基因,miR-149C等位基因与汉族人群缺血性脑卒中易感性有一定的相关性。  相似文献   

15.
Carriage frequencies of alleles and genotypes of polymorphic loci of inflammation genes (49A>G CTLA4, 41G>A and 87C>T PDE4D, ?590C>T IL4, ?308A>G TNF, 252G>A LTA, 874A>T IFNG, ?509С>Т, 869T>C and 915G>C TGFB1) were determined in a sample of 200 patients diagnosed with ischemic stroke and in the control group similar in gender and age (146 individuals), all ethnic Russians. The positive association of the allele PDE4D*87C (р = 0.028) and genotype TGFB1*?509Т/Т (р = 0.02) carriage with ischemic stroke was shown. The association of the disease with the carriage of the allele PDE4D*41А (р = 0.009) in individuals under the age of 60 and with carriage of the allele IFNG*874Т (р = 0.02) in individuals older than 60 was observed among the subgroups of patients stratified by age when they suffered the stroke compared to a control group of the same age. In subgroups stratified by gender, carriage of the genotype TGFB1*915G/G (р = 0.0015) was identified as a risk factor in male patients, while no significant differences between female patients and healthy women were observed. Multilocus analysis was undertaken to search for the association of several combinations of studied gene variants with ischemic stroke. The polymorphic locus–174G>C of the IL6 gene, for which an association with the disease was previously demonstrated, was also included in this analysis. The disease-predisposing biallelic combinations include the IL6*?174G, PDE4D*87C, TGFB1*?509Т and TGFB1*915G alleles. In the subgroups stratified by gender, the allelic combinations mainly include the similar risk alleles as in the total group, while between the subgroups stratified by age (patients who suffered the first stroke at the age of 18 and no older than 60 years and older than 60 years), greater differences were observed. However, a new risk allele, LTA*252G, was identified in combination with PDE4D*41А in women. These findings demonstrate the important role of inflammation in ischemic stroke. The identified single and combined markers may be used further to determine an individual risk for ischemic stroke.  相似文献   

16.
Transforming growth factor beta-1 (TGFB1) may influence asthma by modulating allergic airway inflammation and airway remodeling. The role of single nucleotide polymorphisms (SNPs) of TGFB1 in asthma remains inconclusive. We examined TGFB1 SNPs in relation to asthma risk and degree of atopy among 546 case-parent triads, consisting of asthmatics aged 4–17 years and their parents in Mexico City. Atopy to 24 aeroallergens was determined by skin prick tests. We genotyped five TGFB1 SNPs, including two known functional SNPs [C-509T (rs1800469), T869C (rs1982073)] and three others (rs7258445, rs1800472, rs8179181), using TaqMan and Masscode assays. We analyzed the data using log-linear and polytomous logistic methods. Three associated SNPs, including the two known functional SNPs, were statistically significantly related to asthma risk. Individuals carrying the T allele of C-509T had an increased risk of asthma [relative risk (RR) = 1.42, 95% confidence interval (CI) = 1.08–1.87 for one copy; RR (95%CI) = 1.95 (1.36–2.78) for two copies]. For T869C, the RRs (95%CI) were 1.47 (1.09–1.98) for one and 2.00 (1.38–2.90) for two copies of the C allele. Similar results were found for rs7258445. The haplotype containing all three risk alleles conferred an increased risk of asthma (RR = 1.48, 95% CI = 1.11–1.95 for one copy; RR = 1.77, 95% CI = 1.22–2.57 for two copies). These three SNPs were also related to the degree of atopy. This largest study to date of genetic variation in TGFB1 and asthma and atopy adds to increasing evidence for a role in these disorders.  相似文献   

17.
《Cytokine》2008,41(3):177-182
Susceptibility to tuberculosis (TB) may be affected by host genetic factors. Elevated levels of transforming growth factor-beta 1 (TGF-β1) were found in plasma of patients with active TB compared with those of healthy contacts. To investigate the association of TGF-β1 gene polymorphisms (C-509T and T869C) and plasma levels with the risk of TB in Hong Kong Chinese adults, a case-control study was carried out on 174 active TB patients and 174 healthy controls matched for age, gender and smoking. Blood samples from 180 blood donors served as another control group. Genotyping was carried out on genomic DNA using polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP). Plasma TGF-β1 was measured by commercially available ELISA kit. We found no differences in the distribution of genotypes or alleles of TGF-β1 gene polymorphisms at C-509T and T869C between patients and either group of healthy controls. Patients with TB had elevated plasma TGF-β1 levels compared with healthy controls irrespective of their genotypes (p < 0.001). In conclusion, TGF-β1 gene polymorphism at C-509T and T869C is not associated with TB susceptibility in Hong Kong Chinese adults, but elevated plasma TGF-β1 levels suggests that this cytokine may play a role in the pathogenesis of tuberculosis.  相似文献   

18.
Susceptibility to tuberculosis (TB) may be affected by host genetic factors. Elevated levels of transforming growth factor-beta 1 (TGF-β1) were found in plasma of patients with active TB compared with those of healthy contacts. To investigate the association of TGF-β1 gene polymorphisms (C-509T and T869C) and plasma levels with the risk of TB in Hong Kong Chinese adults, a case-control study was carried out on 174 active TB patients and 174 healthy controls matched for age, gender and smoking. Blood samples from 180 blood donors served as another control group. Genotyping was carried out on genomic DNA using polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP). Plasma TGF-β1 was measured by commercially available ELISA kit. We found no differences in the distribution of genotypes or alleles of TGF-β1 gene polymorphisms at C-509T and T869C between patients and either group of healthy controls. Patients with TB had elevated plasma TGF-β1 levels compared with healthy controls irrespective of their genotypes (p < 0.001). In conclusion, TGF-β1 gene polymorphism at C-509T and T869C is not associated with TB susceptibility in Hong Kong Chinese adults, but elevated plasma TGF-β1 levels suggests that this cytokine may play a role in the pathogenesis of tuberculosis.  相似文献   

19.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号